Yet, while their ability to reduce body weight and insulin levels was greater than GLP1 monotherapy in male models 33,34,35 , the potential of these GLP1-based multi-agonists for the treatment of the metabolic, hormonal, and gonadal complications associated with PCOS has not been explored to date
At Peptira Peps, we supply retatrutide exclusively for laboratory research purposes
You do not know what is in them, what the actual dose is, or what the long-term effects are
Considerations for Canadian Users Retatrutide research and eventual availability involves unique factors for Canadians
The Bottom Line Whether or not you are breastfeeding, using a GLP-1 medication in the postpartum period is a personal decision that deserves careful consideration